Corrigendum: R-carvedilol, a potential new therapy for Alzheimer’s disease
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1125890/full |
_version_ | 1797955224224137216 |
---|---|
author | Jinjing Yao Jinjing Yao S. R. Wayne Chen S. R. Wayne Chen |
author_facet | Jinjing Yao Jinjing Yao S. R. Wayne Chen S. R. Wayne Chen |
author_sort | Jinjing Yao |
collection | DOAJ |
first_indexed | 2024-04-10T23:30:51Z |
format | Article |
id | doaj.art-9bdec0d8e04d46f2b6ede1f1e796d9f6 |
institution | Directory Open Access Journal |
issn | 1663-9812 |
language | English |
last_indexed | 2024-04-10T23:30:51Z |
publishDate | 2023-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj.art-9bdec0d8e04d46f2b6ede1f1e796d9f62023-01-12T06:59:48ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-01-011310.3389/fphar.2022.11258901125890Corrigendum: R-carvedilol, a potential new therapy for Alzheimer’s diseaseJinjing Yao0Jinjing Yao1S. R. Wayne Chen2S. R. Wayne Chen3Department of Physiology and Pharmacology, Cumming School of Medicine, Libin Cardiovascular Institute, University of Calgary, Calgary, AB, CanadaDepartment of Physiology and Pharmacology, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, CanadaDepartment of Physiology and Pharmacology, Cumming School of Medicine, Libin Cardiovascular Institute, University of Calgary, Calgary, AB, CanadaDepartment of Physiology and Pharmacology, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canadahttps://www.frontiersin.org/articles/10.3389/fphar.2022.1125890/fullcarvedilolR-carvedilolAlzheimer’s diseaseRyR2neuronal hyperactivity |
spellingShingle | Jinjing Yao Jinjing Yao S. R. Wayne Chen S. R. Wayne Chen Corrigendum: R-carvedilol, a potential new therapy for Alzheimer’s disease Frontiers in Pharmacology carvedilol R-carvedilol Alzheimer’s disease RyR2 neuronal hyperactivity |
title | Corrigendum: R-carvedilol, a potential new therapy for Alzheimer’s disease |
title_full | Corrigendum: R-carvedilol, a potential new therapy for Alzheimer’s disease |
title_fullStr | Corrigendum: R-carvedilol, a potential new therapy for Alzheimer’s disease |
title_full_unstemmed | Corrigendum: R-carvedilol, a potential new therapy for Alzheimer’s disease |
title_short | Corrigendum: R-carvedilol, a potential new therapy for Alzheimer’s disease |
title_sort | corrigendum r carvedilol a potential new therapy for alzheimer s disease |
topic | carvedilol R-carvedilol Alzheimer’s disease RyR2 neuronal hyperactivity |
url | https://www.frontiersin.org/articles/10.3389/fphar.2022.1125890/full |
work_keys_str_mv | AT jinjingyao corrigendumrcarvedilolapotentialnewtherapyforalzheimersdisease AT jinjingyao corrigendumrcarvedilolapotentialnewtherapyforalzheimersdisease AT srwaynechen corrigendumrcarvedilolapotentialnewtherapyforalzheimersdisease AT srwaynechen corrigendumrcarvedilolapotentialnewtherapyforalzheimersdisease |